Employment Type: Permanent Full Time
Position Classification: Senior Hospital Scientist I/C of Section
Remuneration: $108,607 - $115,143 per annum plus Superannuation
Hours Per Week: 38
Requisition ID: REQ480559
Are you looking for an environment that will ensure a high standard of professional performance which supports education, research and professional development?
About Us
Sydney Local Health District is one of the fastest growing Local Health Districts in New South Wales. Our facilities and services are world class and our staff are dedicated, innovative and caring.
Where you will be based
Formed in 1882, Royal Prince Alfred Hospital (RPAH) is a major metropolitan tertiary referral hospital and a principal provider of specialist healthcare. It remains one of the nation’s most respected hospitals, with a distinguished history serving the health needs of local, statewide, national and international communities.
About the role
Project management and manufacture of human cellular therapeutics in the clean room laboratories of the Department of Cell & Molecular Therapies (CMT) at Royal Prince Alfred Hospital.
We are looking for someone who has…
- An appropriate science degree from an approved University in a relevant discipline, or equivalent.
- Extensive experience in a medical scientific laboratory environment with specific experience in mammalian cell culture, preferably human primary cells.
- In depth knowledge and/or strong experience in at least two of the following disciplines: cell or tissue engineering, biochemistry, haematology, immunology or virology. Demonstrated ability to analyse and resolve problems in complex cell biology systems and procedures.
What we can offer you (for eligible employees)…
- Accrued Day Off (ADO) for full time employees
- Opportunity for extra tax savings through Salary Packaging
- Novated Leasing
- Access to our Employee Assistance Program (EAP) for staff and family members
- Fitness Passport
- Great education opportunities through the Sydney Education
About working for SLHD
Applications Close: 7 June 2024